Akram Yazdani

Akram Yazdani

Auto-generated profile, based on publicly available information

Akram Yazdani

Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Breast Cancer: Basic and Clinical Research
Verified
Journal Article
Open access
PDF file
AYAkram Yazdani
Akram Yazdani
MYMehdi Yaseri
Mehdi Yaseri
SHShahpar Haghighat
Shahpar Haghighat
Ahmad KavianiAhmad Kaviani
Ahmad Kaviani
HZHojjat Zeraati
Hojjat Zeraati
Background: Using data from different health centers can provide more accurate knowledge of the survival prognostic factors and their effect on the patient’s survival. In this multicenter study, we aimed to investigate the role of prognostic factors on breast cancer survival with large data set. Methods: This historical cohort study was carried out using data from 1785 participants with breast cancer. Data were gathered from medical records of patients referring to 4 breast cancer research centers in Tehran, Iran, between 1997 and 2013. Age at diagnosis (year), size of the tumor, involve lymph nodes, tumor grade, type of surgery, auxiliary treatment of chemotherapy, radiotherapy, recurrence, and metastasis were the prognosis factors considered in this study. A shared frailty model with a gamma distribution for frailty term was used. Results: The median follow-up period was 29.71 months with the interquartile range of 19 to 61 months. During the follow-up period, 337 (18.9%) patients died from breast cancer and 1448 (81.1%) survived. The 1-, 3-, 5-, and 10-year survival rates were 96%, 84%, 76%, and 58%, respectively. In the Cox model by centers, in Center A, the type of surgery, number of nodes involved, and the grade 3 tumor; in center B, age, radiotherapy, metastasis, and between 1 and 3 involved nodes; in center C, age, radiotherapy, recurrence, metastasis, tumor size, and grade 3 tumor; and in center D, chemotherapy, metastasis, and lymph nodes involved were significant. Shared frailty model showed that type of surgery, number of lymph nodes involved, metastasis, radiotherapy, and the tumor grade are the prognostic factors survival in breast cancer. The frailty variance was significant, and it affirmed there was significant variability between centers. Conclusions: This study showed it is necessary to consider the frailty term in modeling multicenter survival studies and confirmed the importance of early diagnosis of cancer before the involvement of lymph nodes and the onset of metastasis and timely treatment could lead to longer life and increased quality of life for patients.

1 January 2022 in Breast Cancer: Basic and Clinical Research
Verified
Journal Article
Open access
AYAkram Yazdani
Akram Yazdani
SHShahpar Haghighat
Shahpar Haghighat
Background: The analysis of disease-free survival and related factors leads to a better understanding of the patient’s condition and recurrence-related characteristics and provides a basis for more appropriate treatment guidance. In this study, we aimed to investigate the role of prognostic factors on disease-free survival in breast cancer with a quantile regression model. Methods: This retrospective study was conducted by reviewing data obtained from 2056 breast cancer patients. Age at diagnosis and education status, tumor size, lymph node ratio, tumor grade, estrogen receptor and progesterone receptor, type of surgery, use of radiotherapy, chemotherapy, and hormone therapy were the prognosis factors considered in this study. A quantile regression model was used to investigate prognostic factors of disease-free survival in breast cancer. Results: Disease recurrence was verified in 251 (13.9%) women, and 39 (0.02%) women died before experience recurrence. The 10th percentile of disease-free survival for patients with the hormone therapy was 23.85 months greater than patients who did not receive this treatment ( P value < .001). In the examination of the tumor size, the 10th and 20th percentiles of disease-free survival for patients with tumor size > 5 cm were 31.06 and 27 months less than patients with the tumor size < 2 cm, respectively ( P value = .006 and .021, respectively). Compared with grade 1 tumors, the 10th and 20th percentiles of disease-free survival for patients with grade 3 tumors decreased 30.11 and 38.32 months, respectively ( P value < .001 and .038, respectively). The 10th and 20th percentiles of disease-free survival decreased 28.16 and 45.32 months with a 1 unit increase in lymph node ratio, respectively ( P value = .032 and .032, respectively). Conclusions: Among the prognostic factors, tumor size, grade, and lymph node ratio showed a close relationship with disease-free survival in breast cancer. The findings indicated that developing public screening and educational programs through the health care system with more emphasis on low-educated women is needed among Iranian women.

1 August 2016 in International Journal of Education and Literacy Studies
Verified
Journal Article
Open access
AYAkram Yazdani
Akram Yazdani
HSHadi Salehi
Hadi Salehi

1 January 2023 in Health Services Research and Managerial Epidemiology
Verified
Journal Article
Open access
AYAkram Yazdani
Akram Yazdani
HZHojjat Zeraati
Hojjat Zeraati
SHShahpar Haghighat
Shahpar Haghighat
AKAhmad Kaviani
Ahmad Kaviani
MYMehdi Yaseri
Mehdi Yaseri
Background: The prognostic factors of survival can be accurately identified using data from different health centers, but the structure of multi-center data is heterogeneous due to the treatment of patients in different centers or similar reasons. In survival analysis, the shared frailty model is a common way to analyze multi-center data that assumes all covariates have homogenous effects. We used a censored quantile regression model for clustered survival data to study the impact of prognostic factors on survival time. Methods: This multi-center historical cohort study included 1785 participants with breast cancer from four different medical centers. A censored quantile regression model with a gamma distribution for the frailty term was used, and p-value less than 0.05 considered significant. Results: The 10th and 50th percentiles (95% confidence interval) of survival time were 26.22 (23–28.77) and 235.07 (130–236.55) months, respectively. The effect of metastasis on the 10th and 50th percentiles of survival time was 20.67 and 69.73 months, respectively (all p-value < 0.05). In the examination of the tumor grade, the effect of grades 2 and 3 tumors compare with the grade 1 tumor on the 50th percentile of survival time were 22.84 and 35.89 months, respectively (all p-value < 0.05). The frailty variance was significant, which confirmed that, there was significant variability between the centers. Conclusions: This study confirmed the usefulness of a censored quantile regression model for cluster data in studying the impact of prognostic factors on survival time and the control effect of heterogeneity due to the treatment of patients in different centers.

7 April 2026 in Journal of PeriAnesthesia Nursing
Verified
Journal Article
Closed access
MZMohammadreza Zarei
Mohammadreza Zarei
MGMaryam Ghaffari
Maryam Ghaffari
MRMahboubeh Rezaei
Mahboubeh Rezaei
AYAkram Yazdani
Akram Yazdani
MSMohammad Ali Saadati
Mohammad Ali Saadati

1 July 2026 in Journal of Medical Education Development
Verified
Journal Article
Open access
PDF file
HRHasan Rahmani
Hasan Rahmani
FMFakhrosadat Mirhosseini
Fakhrosadat Mirhosseini
ANAli Norouzi
Ali Norouzi
AYAkram Yazdani
Akram Yazdani
Background & Objective: Motivation is essential for learning, but sustaining it over time requires active self-regulation. This study aimed to develop and psychometrically evaluate a 33-item adaptation of a motivational self-regulation instrument for health students. Confirmatory factor analysis (CFA) was conducted to determine whether the original seven-factor structure was retained in this population. ...